Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZK-261991 is an orally active inhibitor of VEGFR tyrosine kinase(IC50 of 5 nM, VEGFR2).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | ZK-261991 is an orally active inhibitor of VEGFR tyrosine kinase(IC50 of 5 nM, VEGFR2). |
Targets&IC50 | VEGFR2:5 nM |
In vitro | ZK-261991 inhibits cellular receptor autophosphorylation in KDR-PAECs(IC50 of 2 nM). ZK991 inhibits VEGFR-3 autophosphorylation concentration dependently(IC50 of 20 nM). |
Molecular Weight | 443.5 |
Formula | C24H25N7O2 |
CAS No. | 886563-25-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZK-261991 886563-25-3 Angiogenesis Chromatin/Epigenetic HIF ZK 261991 ZK261991 inhibitor inhibit